By performing functional genetic screening, Tsukamoto and colleagues showed that EGCG binding to 67LR receptor induces PP2A activation mediated by the cAMP/PKA pathway [86], which led to the suppression of melanoma tumor cell growth. This evidence concerns the gene PTPA and neoplasm.